Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
AJNR. American Journal of Neuroradiology|October 9, 2007
Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disordersD J Rigotti, M Inglese, O GonenAJNR. American Journal of Neuroradiology|January 11, 2007
Reproducibility of the whole-brain N-acetylaspartate level across institutions, MR scanners, and field strengthsB Benedetti, D J Rigotti, S Liu, et al.AJNR. American Journal of Neuroradiology|April 23, 2011
Longitudinal whole-brain N-acetylaspartate concentration in healthy adultsD J Rigotti, I I Kirov, B Djavadi, et al.AJNR. American Journal of Neuroradiology|October 23, 2010
Global N-acetylaspartate declines even in benign multiple sclerosisD J Rigotti, O Gonen, R I Grossman, et al.AJNR. American Journal of Neuroradiology|September 26, 2007
Serial whole-brain N-acetylaspartate concentration in healthy young adultsD J Rigotti, M Inglese, J S Babb, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 17, 2011
Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessmentD J Rigotti, A Gass, L Achtnichts, et al.AJNR. American Journal of Neuroradiology|June 17, 2008
Whole-brain N-acetylaspartate MR spectroscopic quantification: performance comparison of metabolite versus lipid nullingJ-B Hövener, D J Rigotti, M Amann, et al.Neurology|April 21, 2012
Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosisD J Rigotti, M Inglese, I I Kirov, et al.Molecular Cell|January 10, 2002
Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signalingJ W Wu, M Hu, J Chai, et al.Pageof 1